vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and IREN Ltd (IREN). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $184.7M, roughly 1.9× IREN Ltd). HAEMONETICS CORP runs the higher net margin — 28.1% vs -84.1%, a 112.2% gap on every dollar of revenue. On growth, IREN Ltd posted the faster year-over-year revenue change (59.0% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $-468.0M).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada.
HAE vs IREN — Head-to-Head
Income Statement — Q4 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $346.4M | $184.7M |
| Net Profit | $97.3M | $-155.4M |
| Gross Margin | 57.2% | 64.4% |
| Operating Margin | 36.1% | -63.0% |
| Net Margin | 28.1% | -84.1% |
| Revenue YoY | 4.8% | 59.0% |
| Net Profit YoY | — | -610.0% |
| EPS (diluted) | — | $-0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $184.7M | ||
| Q3 25 | $327.3M | $240.3M | ||
| Q2 25 | $321.4M | — | ||
| Q1 25 | $330.6M | — | ||
| Q4 24 | $348.5M | $116.1M | ||
| Q3 24 | $345.5M | $52.8M | ||
| Q2 24 | $336.2M | — |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $-155.4M | ||
| Q3 25 | $38.7M | $384.6M | ||
| Q2 25 | $34.0M | — | ||
| Q1 25 | $58.0M | — | ||
| Q4 24 | $37.5M | $-21.9M | ||
| Q3 24 | $33.8M | $-51.7M | ||
| Q2 24 | $38.4M | — |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | 64.4% | ||
| Q3 25 | 59.5% | 66.4% | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | 72.2% | ||
| Q3 24 | 54.2% | 39.6% | ||
| Q2 24 | 52.0% | — |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | -63.0% | ||
| Q3 25 | 17.9% | -31.8% | ||
| Q2 25 | 16.8% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 16.9% | 14.9% | ||
| Q3 24 | 15.0% | -89.2% | ||
| Q2 24 | 11.8% | — |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | -84.1% | ||
| Q3 25 | 11.8% | 160.1% | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 17.5% | — | ||
| Q4 24 | 10.8% | -18.8% | ||
| Q3 24 | 9.8% | -98.0% | ||
| Q2 24 | 11.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $-0.52 | ||
| Q3 25 | $0.81 | $1.08 | ||
| Q2 25 | $0.70 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $0.74 | $-0.10 | ||
| Q3 24 | $0.66 | $-0.27 | ||
| Q2 24 | $0.74 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $3.3B |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $796.3M | $2.5B |
| Total Assets | $2.4B | $7.0B |
| Debt / EquityLower = less leverage | 1.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $3.3B | ||
| Q3 25 | $296.4M | $1.0B | ||
| Q2 25 | $292.9M | — | ||
| Q1 25 | $306.8M | — | ||
| Q4 24 | $320.8M | $427.3M | ||
| Q3 24 | $299.3M | $98.6M | ||
| Q2 24 | $344.4M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $2.5B | ||
| Q3 25 | $849.2M | $2.9B | ||
| Q2 25 | $882.3M | — | ||
| Q1 25 | $820.8M | — | ||
| Q4 24 | $906.9M | $1.2B | ||
| Q3 24 | $878.9M | $1.1B | ||
| Q2 24 | $905.4M | — |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $7.0B | ||
| Q3 25 | $2.4B | $4.3B | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | $1.9B | ||
| Q3 24 | $2.5B | $1.3B | ||
| Q2 24 | $2.5B | — |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | $71.7M |
| Free Cash FlowOCF − Capex | $209.9M | $-468.0M |
| FCF MarginFCF / Revenue | 60.6% | -253.4% |
| Capex IntensityCapex / Revenue | 9.5% | 292.2% |
| Cash ConversionOCF / Net Profit | 3.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | $-701.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $71.7M | ||
| Q3 25 | $111.3M | $142.4M | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $116.6M | — | ||
| Q4 24 | $43.8M | $53.6M | ||
| Q3 24 | $48.8M | $-3.9M | ||
| Q2 24 | $-27.4M | — |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | $-468.0M | ||
| Q3 25 | $106.3M | $-38.0M | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $35.2M | $-85.5M | ||
| Q3 24 | $39.4M | $-109.7M | ||
| Q2 24 | $-33.1M | — |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | -253.4% | ||
| Q3 25 | 32.5% | -15.8% | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 10.1% | -73.6% | ||
| Q3 24 | 11.4% | -208.0% | ||
| Q2 24 | -9.8% | — |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | 292.2% | ||
| Q3 25 | 1.5% | 75.0% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 2.5% | 119.7% | ||
| Q3 24 | 2.7% | 200.6% | ||
| Q2 24 | 1.7% | — |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | — | ||
| Q3 25 | 2.88× | 0.37× | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.01× | — | ||
| Q4 24 | 1.17× | — | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
IREN
| Bitcoin Mining Revenue | $167.4M | 91% |
| AI Cloud Services | $17.3M | 9% |
